Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy.

Hessling K, Brand C, Schwöppe C, Gerwing M, Pavelka S, Berdel AF, Hintelmann H, Hamacher R, Müller-Tidow C, Egerer G, Hartmann W, Grünewald I, Lindner LH, Di Gioia D, Hecker JS, Maurer S, Pink D, Fried M, Zapata Bonilla SA, Scheuble AM, Lordick F, Ivanyi P, Fobker M, Lenz G, Gerss J, Kessler T, Berdel WE, Schliemann C

Open source

DOI: 10.1038/s41598-026-40362-4
Published: 2026 Feb 19
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-40362-4,
  title = {Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy.},
  author = {Hessling K and Brand C and Schwöppe C and Gerwing M and Pavelka S and Berdel AF and Hintelmann H and Hamacher R and Müller-Tidow C and Egerer G and Hartmann W and Grünewald I and Lindner LH and Di Gioia D and Hecker JS and Maurer S and Pink D and Fried M and Zapata Bonilla SA and Scheuble AM and Lordick F and Ivanyi P and Fobker M and Lenz G and Gerss J and Kessler T and Berdel WE and Schliemann C},
  year = {2026},
  journal = {Scientific reports},
  doi = {10.1038/s41598-026-40362-4},
  url = {https://doi.org/10.1038/s41598-026-40362-4}
}

RIS

TY  - JOUR
TI  - Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy.
AU  - Hessling K
AU  - Brand C
AU  - Schwöppe C
AU  - Gerwing M
AU  - Pavelka S
AU  - Berdel AF
AU  - Hintelmann H
AU  - Hamacher R
AU  - Müller-Tidow C
AU  - Egerer G
AU  - Hartmann W
AU  - Grünewald I
AU  - Lindner LH
AU  - Di Gioia D
AU  - Hecker JS
AU  - Maurer S
AU  - Pink D
AU  - Fried M
AU  - Zapata Bonilla SA
AU  - Scheuble AM
AU  - Lordick F
AU  - Ivanyi P
AU  - Fobker M
AU  - Lenz G
AU  - Gerss J
AU  - Kessler T
AU  - Berdel WE
AU  - Schliemann C
PY  - 2026
JO  - Scientific reports
DO  - 10.1038/s41598-026-40362-4
UR  - https://doi.org/10.1038/s41598-026-40362-4
ER  -

APA

K, H., C, B., C, S., M, G., S, P., AF, B., H, H., R, H., C, M., G, E., W, H., I, G., LH, L., D, D. G., JS, H., S, M., D, P., M, F., SA, Z. B., AM, S., F, L., P, I., M, F., G, L., J, G., T, K., WE, B., & C, S. (2026). Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy.. Scientific reports. https://doi.org/10.1038/s41598-026-40362-4

Source records

pubmed · retrieved 2026-09-25T17:25:56.288Z
europe-pmc · retrieved 2026-09-25T17:25:56.302Z